Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Subject: Schizophrenia - PUBLISHED VIA Translational Psychiatry
Author(s):
Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C, Klosterkötter J, Hellmich M, Koethe D
View Source >>
Related Studies:
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.
Published via Current Pharmaceutical Design
Cannabidiol as a potential treatment for psychosis.
Published via European Neuropsychopharmacology
Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
Published via Drug Testing and Analysis
Peripheral endocannabinoid system dysregulation in first-episode psychosis.
Published via Neuropsychopharmacology
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
Published via Brazilian Journal of Medical and Biological Research